Did you know?

ChinaBio® Group is a consulting and advisory firm helping life science companies and investors achieve success in China. ChinaBio works with U.S., European and APAC companies and investors seeking partnerships, acquisitions, novel technologies and funding in China.  

Learn more >>

Free Newsletter

Have the latest stories on China's life science industry delivered to your inbox daily or weekly - free!

  Email address:

Sinovac Announces Positive Phase III Results for Chickenpox Vaccine

publication date: Sep 26, 2017

Sinovac Biotech, a Beijing vaccine company, reported positive topline results from a Phase III trial of its Varicella vaccine against chickenpox. The new vaccine was both safe and effective in two large-scale China trials that enrolled children from one to twelve years old. In its release, Sinovac discussed its newest vaccine, but did not report any new developments in the company's long-running privatization battle. More details....

Stock Symbol: (NSDQ: SVA)

Share this with colleagues:

This article is available for purchase - please click here for details.

Sorry this page is available to subscribers only.
If you're not a subscriber why not subscribe today?

If you are already a subscriber, please login.

If you believe you should have received this message in error, please contact us.


To gain access to the members only content click here to subscribe.

You will be given immediate access to premium content on the site.

ChinaBio Event
Shanghai and Digital
May 10-14, 2021
ChinaBio® News

Greg Scott BIO-Europe Interview
Greg Scott Interviewed at BIO-Europe Spring

How to bring your China assets to China in 8 minutes

Greg Scott Mendelspod Interview
"Mr. Bio in China."
Mendelspod Interview

Multinational pharma held to a higher standard in China